Skip to content
HealthTech Series B Founded 2022

Econic Biosciences

Developer of a platform for the discovery and development of targeted therapies for cancer

📍 London, United Kingdom · Life Sciences Tech

Funding snapshot

Last roundSeries B
Amount$5M
Date16 May 2024

About

Developer of a platform for the discovery and development of targeted therapies for cancer. It uses AI to identify and characterize ecDNA which is a mediator of oncogenic gene amplification and a potent driver of tumor evolution. It enables the development of therapies that specifically target ecDNA for cancer patients.

Latest news

No articles yet.

Raising like Econic Biosciences?

Analyze your pitch deck before your next raise.

Analyze My Deck →